Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Morphine anticorps (HRP)

ELISA Hôte: Souris Monoclonal 2F11 HRP
N° du produit ABIN723285
  • Antigène Tous les produits Morphine
    Morphine
    Reactivité
    Veuillez nous consulter SVP
    Hôte
    • 15
    • 5
    • 3
    • 1
    Souris
    Clonalité
    • 15
    • 9
    Monoclonal
    Conjugué
    • 16
    • 3
    • 2
    • 1
    • 1
    • 1
    Cet anticorp Morphine est conjugé à/à la HRP
    Application
    • 20
    • 6
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    ELISA
    Réactivité croisée (Details)
    Morphine
    Purification
    Purified by Protein G.
    Immunogène
    KLH conjugated Morphine molecular modified
    Clone
    2F11
    Isotype
    IgG
  • Indications d'application
    ELISA 1:500-1000
    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    1 μg/μL
    Buffer
    Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
    Agent conservateur
    Gentamicin sulfate
    Précaution d'utilisation
    This product contains Gentamicin sulfate: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Conseil sur la manipulation
    Do NOT add Sodium Azide! Use of Sodium Azide will inhibit enzyme activity of horseradish peroxidase.
    Stock
    -20 °C
    Stockage commentaire
    Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
    Date de péremption
    12 months
  • Antigène
    Morphine
    Abstract
    Morphine Produits
    Classe de substances
    Chemical
    Sujet

    Synonyms: Morphine 6.

    Background: Morphine is thought to produce reinforcement phenomena via stimulation of mu, delta, and kappa opioid receptors that regulate stress perception, pain control, reward behavior, and neurohormone secretion in reward-relevant brain systems. It has the highest affinity for mu, followed by delta and kappa. Rapid activation of the mu opioid receptor by morphine results in a euphoric phenotype, thus conferring the reinforcing effects of the drug. This activation is accompanied by extracellular dopamine release, which alters several events related to the cAMP signal transduction pathway. Of particular significance is that CREB seems to be modified by morphine, thereby affecting addictive behavioral phenomena, such as withdrawal symptoms.

Vous êtes ici:
Support technique